296
Views
2
CrossRef citations to date
0
Altmetric
Articles

Zolpidem as a high risk factor for elderly suicide in South Korea

REFERENCES

  • Ben-Hamou, M., Marshall, N. S., Grunstein, R. R., Saini, B., & Fois, R. A. (2011). Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008. Journal of Sleep Research, 20(4), 559–568. doi:10.1111/j.1365-2869.2011.00919.x
  • Bertisch, S. M., Herzig, S. J., Winkelman, J. W., & Buettner, C. (2014). National use of prescription medications for insomnia: NHANES 1999–2010. Sleep, 37(2), 343–349. doi:10.5665/sleep.3410
  • Choi, Y., Lee, M. H., Choi, J. W., Kim, S., Kim, J., & Lee, Y. J. (2016). Survey of insomnia treatment status for doctors. Sleep Medicine and Psychophysiology, 23(2), 77–83. doi:10.14401/KASMED.2016.23.2.77
  • Chung, S., Park, B., Yi, K., & Lee, J. (2013). Pattern of hypnotic drug prescription in South Korea: Health Insurance Review and Assessment Service—National Patients Sample. Sleep Medicine Research, 4(2), 51–55. doi:10.17241/smr.2013.4.2.51
  • Darke, S., Deady, M., & Duflou, J. (2012). Toxicology and characteristics of deaths involving zolpidem in New South Wales, Australia 2001-2010. Journal of Forensic Sciences, 57(5), 1259–1262. doi:10.1111/j.1556-4029.2012.02117.x
  • European Medicine Agency. (2016). EudraVigilance (EV). Retrieved from http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000679.jsp&mid=WC0b01ac05800250b5.
  • Food and Drug Administration. (2019). Last update, FDA Drug Safety Communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using AmbienCR. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fdaapproves-new-label-changes-and-dosing-zolpidem-products-and.
  • Ford, E. S., Wheaton, A. G., Cunningham, T. J., Giles, W. H., Chapman, D. P., & Croft, J. B. (2014). Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: Findings from the National Ambulatory Medical Care survey 1999–2010. Sleep, 37(8), 1283–1293. doi:10.5665/sleep.3914
  • Hamilton, J. L., & Buysse, D. J. (2019). Reducing suicidality through insomnia treatment: Critical next steps in suicide prevention. The American Journal of Psychiatry, 176 (11), 897–899. doi:10.1176/appi.ajp.2019.19080888
  • Isacsson, G., & Ahlner, J. (2014). Antidepressants and the risk of suicide in young persons-prescription trends and toxicological analyses. Acta Psychiatrica Scandinavica, 129(4), 296–302. doi:10.1111/acps.12160
  • Jones, C. M., & McAninch, J. K. (2015). Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. American Journal of Preventive Medicine, 49 (4), 493–501. doi:10.1016/j.amepre.2015.03.040
  • Kang, D. Y., Park, S., Rhee, C. W., Kim, Y. J., Choi, N. K., Lee, J., & Park, B. J. (2012). Zolpidem use and risk of fracture in elderly insomnia patients. Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi, 45(4), 219–226. doi:10.3961/jpmph.2012.45.4.219
  • Kim, B., Ahn, J. H., Cha, B., Chung, Y. C., Ha, T. H., Jeong, S. H., … Ahn, Y. M. (2015). Characteristics of methods of suicide attempts in Korea: Korea National Suicide Survey (KNSS). Journal of Affective Disorders, 188, 218–225. doi:10.1016/j.jad.2015.08.050
  • Kim, K. W., Kang, S. H., Yoon, I. Y., Lee, S. D., Ju, G., Han, J. W., … Kim, T. (2017). Prevalence and clinical characteristics of insomnia and its subtypes in the Korean elderly. Archives of Gerontology and Geriatrics, 68, 68–75. doi:10.1016/j.archger.2016.09.005
  • Kim, S. C., & Lee, Y. J. (2016). Last update: Survey on insomnia treatment and health effect. Retrieved from http://www.ndsl.kr/ndsl/search/detail/report/reportSearchResultDetail.do?cn=TRKO201700000756&SITE=CLICK.
  • Korean Statistical Information Service. (2018). Health and welfare statistical year book 2018. Retrieved from http://kosis.kr/statisticsList/statisticsListIndex.do?menuId=M_01_01&vwcd=MT_ZTITLE&parmTabId=M_01_01&statId=1962001&themaId=A#A1.2.
  • Korean Statistical Information Service. (2019). Cause of death. Retrieved from http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B34E01&conn_path=I2.
  • Korea Suicide Prevention Center. (2019). Last update: Korea, suicide prevention white paper. Retrieved from http://spckorea-stat.or.kr/boadpublishview.do.
  • Kripke, D. F. (2000). Chronic hypnotic use: Deadly risks, doubtful benefit. Sleep Medicine Reviews, 4(1), 5–20. doi:10.1053/smrv.1999.0076
  • Lee, C. A., Choi, S. C., Jung, K. Y., Cho, S. H., Lim, K. Y., Pai, K. S., & Cho, J. P. (2012). Characteristics of patients who visit the emergency department with self-inflicted injury. Journal of Korean Medical Science, 27(3), 307–312. doi:10.3346/jkms.2012.27.3.307
  • Lee, M. H., Choi, J. W., Lee, J., Shin, A., Oh, S. M., Jung, S. J., & Lee, Y. J. (2019). Trends in prescriptions for sedative-hypnotics among Korean adults: A nationwide prescription database study for 2011-2015. Social Psychiatry and Psychiatric Epidemiology, 54(4), 477–484. doi:10.1007/s00127-018-1615-x
  • Lim, J. Y., & Lee, D. H. (2018). Characteristics of drugs ingested for suicide attempts in the elderly. Journal of Korean Medical Science, 33(11), e86. doi:10.3346/jkms.2018.33.e86
  • Manuel, J. I., & Lee, J. (2017). Gender differences in discharge dispositions of emergency department visits involving drug misuse and abuse-2004-2011. Substance Abuse Treatment, Prevention, and Policy, 12(1), 28 doi:10.1186/s13011-017-0114-5
  • McCall, W. V., Benca, R. M., Rosenquist, P. B., Riley, M. A., McCloud, L., Newman, J. C., … Krystal, A. D. (2017). Hypnotic medications and suicide: Risk, mechanisms, mitigation, and the FDA. American Journal of Psychiatry, 174(1), 18–25. doi:10.1176/appi.ajp.2016.16030336
  • Moloney, M. E., Konrad, T. R., & Zimmer, C. R. (2011). The medicalization of sleeplessness: A public health concern. American Journal of Public Health, 101(8), 1429–1433. doi:10.2105/AJPH.2010.300014
  • Moore, T. J., & Mattison, D. R. (2017). Adult utilization of psychiatric drugs and differences by sex, age, and race. JAMA Internal Medicine, 177(2), 274–275. doi:10.1001/jamainternmed.2016.7507
  • Organisation for Economic Co-operation and Development. (2016). OECD health statistics 2016. Paris: Organisation for Economic Co-operation and Development.
  • Organisation for Economic Co-operation and Development. (2019). Suicide rates (indicator). Retrieved from https://data.oecd.org/healthstat/suicide-rates.htm.
  • Schifano, F., Chiappini, S., Corkery, C. J., & Guirguis, A. (2019). An insight into Z-drug abuse and dependence: An examination of reports to the European medicines agency database of suspected adverse drug reactions. The International Journal of Neuropsychopharmacology, 22(4), 270–277. doi:10.1093/ijnp/pyz007
  • Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016). Review of safety and efficacy of sleep medicines in older adults. Clinical Therapeutics, 38(11), 2340–2372. doi:10.1016/j.clinthera.2016.09.010
  • Shah, A. (2007). The relationship between suicide rates and age: An analysis of multinational data from the World Health Organization. International Psychogeriatrics, 19(6), 1141–1152. doi:10.1017/S1041610207005285
  • Siriwardena, A. N., Qureshi, M. Z., Dyas, J. V., Middleton, H., & Orner, R. (2008). Magic bullets for insomnia? Patients’ use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. British Journal of General Practice, 58(551), 417–422. doi:10.3399/bjgp08X299290
  • Stone, K. L., Ensrud, K. E., & Ancoli-Israel, S. (2008). Sleep, insomnia and falls in elderly patients. Sleep Medicine, 9(Suppl 1), S18–S22. doi:10.1016/S1389-9457(08)70012-1
  • Sun, Y., Lin, C. C., Lu, C. J., Hsu, C. Y., & Kao, C. H. (2016). Association between zolpidem and suicide: A nationwide population-based case-control study. Mayo Clinic Proceedings, 91(3), 308–315. doi:10.1016/j.mayocp.2015.10.022
  • Taylor, W. D. (2014). Clinical practice. Depression in the elderly. The New England Journal of Medicine, 371(13), 1228–1236. doi:10.1056/NEJMcp1402180
  • Trockel, M., Karlin, B. E., Taylor, C. B., & Manber, R. (2014). Cognitive behavioral therapy for insomnia with veterans: Evaluation of effectiveness and correlates of treatment outcomes. Behaviour Research and Therapy, 53, 41–46. doi:10.1016/j.brat.2013.11.006
  • Unutzer, J., Katon, W., Callahan, C. M., Williams, J. W., Jr., Hunkeler, E., Harpole, L., … Oishi, S. (2003). Depression treatment in a sample of 1,801 depressed older adults in primary care. Journal of the American Geriatrics Society, 51(4), 505–514. doi:10.1046/j.1532-5415.2003.51159.x
  • Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019). The epidemiology of benzodiazepine misuse: A systematic review. Drug and Alcohol Dependence, 200, 95–114. doi:10.1016/j.drugalcdep.2019.02.033
  • Wong, C. K., Marshall, N. S., Grunstein, R. R., Ho, S. S., Fois, R. A., Hibbs, D. E., … Saini, B. (2017). Spontaneous adverse event reports associated with zolpidem in the United States 2003-2012. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine, 13(2), 223–234. doi:10.5664/jcsm.6452
  • World Health Organization. (2014). Preventing suicide: A global imperative. Geneva: World Health Organization.
  • World Health Organization. (2016). World health statistics 2016: Monitoring health for the SDGs (sustainable development goals). Geneva: World Health Organization.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.